David J. Yvars Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$272K Sell
1,029
-9
-0.9% -$2.37K 0.13% 78
2026
Q2
$264K Sell
1,038
-20
-2% -$4.66K 0.12% 78
2026
Q1
$259K Sell
1,058
-39
-4% -$9.08K 0.14% 67
2025
Q4
$227K Sell
1,097
-10
-0.9% -$1.98K 0.12% 82
2025
Q3
$205K Buy
+1,107
New +$190K 0.11% 88
2024
Q4
– Sell
-1,266
Closed -$205K – 81
2024
Q3
$205K Buy
+1,266
New +$202K 0.13% 74
2024
Q2
– Sell
-1,266
Closed -$200K – 80
2024
Q1
$200K Sell
1,266
-38
-3% -$6.05K 0.14% 69
2023
Q4
$204K Hold
1,304
– – 0.16% 67
2023
Q3
$203K Sell
1,304
-29
-2% -$4.79K 0.17% 68
2023
Q2
$221K Sell
1,333
-5
-0.4% -$807 0.18% 66
2023
Q1
$207K Buy
+1,338
New +$216K 0.19% 67

Other funds holding JNJ

David J. Yvars Group's JNJ Position: Q3 2026 in Review

David J. Yvars Group reduced its Johnson & Johnson (JNJ) stake by 0.87% in Q3 2026, selling an estimated $2.37K and leaving 1,029 shares worth $272K. The position accounts for 0.13% of the portfolio, ranked #78.

David J. Yvars Group first reported a position in JNJ in Q1 2023 and has held it in 11 quarters since. 267 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • David J. Yvars Group held 1,029 shares of Johnson & Johnson worth $272K as of Q3 2026.
  • David J. Yvars Group sold 9 Johnson & Johnson shares in Q3 2026, an estimated $2.37K.
  • Johnson & Johnson made up 0.13% of David J. Yvars Group's portfolio in Q3 2026, its #78 holding.
  • David J. Yvars Group first reported a position in Johnson & Johnson in Q1 2023 and has held it in 11 quarters since.
  • 267 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on David J. Yvars Group's 13F filing for Q3 2026, filed 9 Oct 2026.